Hepatic Steatosis Does Not Increase Portal Pressure in Patients with Chronic Liver Disease

被引:0
|
作者
Scheiner, Bernhard [1 ]
Semmler, Georg [1 ]
Schwabl, Philipp [1 ]
Bucsics, Theresa [1 ]
Paternostro, Rafael [2 ]
Chromy, David [1 ]
Staettermayer, Albert [1 ]
Trauner, Michael H. [1 ]
Mandorfer, Mattias [3 ]
Ferlitsch, Arnulf [4 ]
Reiberger, Thomas [1 ]
机构
[1] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria
[2] Med Univ Vienna, Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria
[3] Vienna HIV & Liver Study Grp, Vienna, Austria
[4] Krankenhaus Barmherzige Bruder, Div Internal Med 2, Vienna, Austria
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
2066
引用
收藏
页码:1177A / 1177A
页数:1
相关论文
共 50 条
  • [31] Does Hepatic Steatosis Affect Drug Metabolizing Enzymes in the Liver?
    Buechler, Christa
    Weiss, Thomas S.
    CURRENT DRUG METABOLISM, 2011, 12 (01) : 24 - 34
  • [32] Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease
    Scheiner, B.
    Steininger, L.
    Semmler, G.
    Schwabl, P.
    Bucsics, T.
    Paternostro, R.
    Ferlitsch, A.
    Trauner, M.
    Reiberger, T.
    Mandorfer, M.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S707 - S708
  • [33] Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease
    Scheiner, Bernhard
    Steininger, Lisa
    Semmler, Georg
    Unger, Lukas W.
    Schwabl, Philipp
    Bucsics, Theresa
    Paternostro, Rafael
    Ferlitsch, Arnulf
    Trauner, Michael
    Reiberger, Thomas
    Mandorfer, Mattias
    LIVER INTERNATIONAL, 2019, 39 (01) : 127 - 135
  • [34] EFFECTS OF PROPRANOLOL ON PORTAL-VEIN PRESSURE, PORTAL BLOOD-FLOW, HEPATIC BLOOD-FLOW, AND CARDIAC-OUTPUT IN PATIENTS WITH CHRONIC LIVER-DISEASE
    NAKAYAMA, T
    OHNISHI, K
    SAITO, M
    HATANO, H
    NOMURA, F
    KONO, K
    OKUDA, K
    HEPATOLOGY, 1983, 3 (05) : 812 - 812
  • [35] Wedged hepatic venous pressure does not reflect portal pressure in patients with cirrhosis and hepatic veno-venous communications
    Osada, Yuji
    Kanazawa, Hidenori
    Narahara, Yoshiyuki
    Mamiya, Yasutaka
    Nakatsuka, Katsuhisa
    Sakamoto, Choitsu
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (01) : 7 - 13
  • [36] Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model
    Lee, Sungmin
    Son, Beomseok
    Jeon, Jaewan
    Park, Gaeul
    Kim, Hyunwoo
    Kang, Hyunkoo
    Youn, HyeSook
    Jo, Sunmi
    Song, Jie-Young
    Youn, BuHyun
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 47 (06) : 2233 - 2249
  • [37] CONTROLLED ATTENUATION PARAMETER (CAP) FOR DETECTION OF HEPATIC STEATOSIS IN PATIENTS WITH CHRONIC LIVER DISEASES
    Tang, H.
    Chen, J.
    Chen, E. -Q.
    Wu, D.
    Bai, L.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S720 - S720
  • [38] Diagnostic accuracy of B-Mode ultrasound and Hepatorenal Index for graduation of hepatic steatosis in patients with chronic liver disease
    Petzold, Golo
    Lasser, Julian
    Ruehl, Janina
    Bremer, Sebastian C. B.
    Knoop, Richard F.
    Ellenrieder, Volker
    Kunsch, Steffen
    Neesse, Albrecht
    PLOS ONE, 2020, 15 (05):
  • [39] DOES STEATOSIS INFLUENCE THE EFFECT OF THERAPY AND THE PROGRESSION OF CHRONIC LIVER DISEASE CAUSED BY HCV?
    Tokushige, Katsutoshi
    Noto, Haruka
    Yatsuji, Satoru
    Taniai, Makiko
    Hashimoto, Etsuko
    Shiratori, Keiko
    HEPATOLOGY, 2008, 48 (04) : 904A - 904A
  • [40] Multiparametric ultrasound evaluation of liver fibrosis, steatosis, and viscosity in patients with chronic liver disease
    Minciuna, Iulia
    Taru, Madalina
    Fodor, Andreea
    Farcau, Oana Nicoara
    Fischer, Petra
    Radu, Corina
    Lupsor-Platon, Monica
    Stefanescu, Horia
    Procopet, Bogdan
    MEDICAL ULTRASONOGRAPHY, 2024, 26 (02) : 117 - 124